Genomics

23-CNR-3647478-CQD-Hero-650×450 Dr Scott Dr Scarborough
April 27, 2023/Genomics

Gene Expression Signature Predicts Patients’ Response to Cisplatin

Research enables precision medicine beyond patients with changed mutational status

Cancer cell, cell grow out of control and become invasive
July 12, 2022/Genomics

Evolutionary Games Have High Stakes in Treatment-Resistant Cancer

Understanding cell growth dynamics may be key to controlling therapeutic resistance

Genomic Laboratory Equipment

New Collaboration Moves the Needle on Precision Medicine

Cleveland Clinic and PGDx employ liquid biopsy technology to enhance patient care and research

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Doctor Talking With a Cancer Patient During Treatment
December 21, 2021/Genomics

Survivorship is the Focus of New Cancer Genomics Program

Specialized clinic addresses long-term wellness through the study of somatic mutations

breastfeeding
June 24, 2021/Genomics

Breastfeeding Cuts Ovarian Cancer Risk in BRCA Mutation Carriers

Other reproductive and hormonal factors found protective

AA-breast-cancer_650x450
June 7, 2021/Genomics

New Polygenic Risk Score for Breast Cancer Accurate for All Ancestries

Improved risk stratification for all women

16-HRT-144-GeneticsCardiomyopathies-CQD-650×450 (2)
June 4, 2021/Genomics

Inherited Risk of Estrogen-Driven Postmenopausal Breast Cancer

Adrenal-permissive HSD3B1 plays a role

PTEN flip-Lerner
March 26, 2021/Genomics

Cleveland Clinic Designated PTEN Clinical Center of Excellence

Clinicians and researchers with unique expertise

prostate-cancer-cell_650x450
October 12, 2018/Genomics

Using Next-Generation Sequencing to Target Tumor Genomics in Metastatic Prostate Cancer

Actionability of tumor DNA data remains limited

BackPage 1 of 2Next
Advertisement
Ad